RESMED INC — Director's Dealing 2022

Aug 22, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2022-08-18

Reporting Person: Farrell Michael J. (Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-08-18	ResMed Common Stock	A	17310	—	Acquired	422570	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
ResMed Common Stock	3880	Indirect
ResMed Common Stock	5090	Indirect

Footnotes

F1: Represents performance-based restricted stock units granted on November 18, 2021. The shares were earned on August 18, 2022, when the compensation committee certified that the performance metrics were met. Stock units vest 1/3 each year on the anniversary of the grant.